enVVeno Medical Corp 8-K

What Happened

• enVVeno Medical Corporation (NVNO) filed a Form 8‑K on July 14, 2026 under Item 7.01 to disclose that it issued an investor presentation. The presentation may be used, in whole or in part and possibly with modifications, at meetings with investors, analysts or others. A copy of the presentation is attached as Exhibit 99.1 to the filing.

Key Details

• Filing date: July 14, 2026 (Form 8‑K, Item 7.01, Regulation FD disclosure).
• Exhibit included: 99.1 — Investor Presentation; Exhibit 104 — Cover Page Interactive Data File (Inline XBRL).
• The company states the 8‑K information and exhibit are not to be deemed “filed” under Section 18 of the Exchange Act or incorporated by reference in other filings unless expressly stated.

Why It Matters

• This is a Reg FD disclosure indicating enVVeno is providing updated corporate or investor-facing materials; it is not an earnings release or a substitute for SEC filings reporting revenue, quarterly results, or other financial statements. Investors should review the attached presentation (Exhibit 99.1) for any updates on strategy, operations, or guidance that management may present in investor meetings.